1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America OTC Drug and Dietary Supplement Market - By Product
1.3.2 North America OTC Drug and Dietary Supplement Market - By Type
1.3.3 North America OTC Drug and Dietary Supplement Market - By Form
1.3.4 North America OTC Drug and Dietary Supplement - By Distribution Channel
1.3.5 North America OTC Drug and Dietary Supplement Market- By Region

2. OTC Drug and Dietary Supplement Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. OTC Drug and Dietary Supplement - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.3 Expert Opinion

5. North America OTC Drug and Dietary Supplement Market - Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Awareness About General Health Issues
5.1.2 Advantages of OTC Drugs
5.2 Market Restraints
5.2.1 Strict FDA Regulations For OTC Drugs
5.3 Market Opportunities
5.3.1 R&D Activities by Market Players to Offer Improved OTC Drugs
5.4 Future Trends
5.4.1 Selection of OTC Drugs for Minor Diseases
5.5 Impact Analysis

6. OTC Drug and Dietary Supplement Market - Regional Analysis
6.1 North America OTC Drug and Dietary Supplement Market Revenue Forecast And Analysis

7. North America OTC Drug and Dietary Supplement Market Analysis - By Product
7.1 Overview
7.2 OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
7.3 Cough and Cold Products
7.3.1 Overview
7.3.2 Cough and Cold Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.4 Vitamins and Dietary Supplements
7.4.1 Overview
7.4.2 Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.5 Analgesics
7.5.1 Overview
7.5.2 Analgesics: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.6 Gastrointestinal Products
7.6.1 Overview
7.6.2 Gastrointestinal Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.7 Sleep Aids
7.7.1 Overview
7.7.2 Sleep Aids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.8 Oral Care Products
7.8.1 Overview
7.8.2 Oral Care Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.9 Ophthalmic Products
7.9.1 Overview
7.9.2 Ophthalmic Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.10 Antacids
7.10.1 Overview
7.10.2 Antacids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.11 Feminine Care
7.11.1 Overview
7.11.2 Feminine Care: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)

8. OTC Drug and Dietary Supplement Analysis - By Type
8.1 Overview
8.2 OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
8.3 Branded
8.3.1 Overview
8.3.2 Branded: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
8.4 Generic
8.4.1 Overview
8.4.2 Generic: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)

9. OTC Drug and Dietary Supplement Analysis - By Form
9.1 Overview
9.2 OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)
9.3 Tablets
9.3.1 Overview
9.3.2 Tablets: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.4 Capsules
9.4.1 Overview
9.4.2 Capsules: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.5 Powders
9.5.1 Overview
9.5.2 Powders: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.6 Ointments
9.6.1 Overview
9.6.2 Ointments: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.7 Liquid
9.7.1 Overview
9.7.2 Liquid: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)

10. OTC Drug and Dietary Supplement Analysis - By Distribution Channel
10.1 Overview
10.2 OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)
10.3 Hospital and Retail Pharmacies
10.3.1 Overview
10.3.2 Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10.4 Retail Stores
10.4.1 Overview
10.4.2 Retail Stores: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)

11. OTC Drug and Dietary Supplement Analysis And Forecasts To 2027 - Geographical Analysis
11.1 North America: OTC Drug and Dietary Supplement Market
11.1.1 Overview
11.1.2 North America: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.4 North America: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.5 North America: OTC Drug and Dietary Supplement Market, By Form - Revenue and Forecast to 2027 (USD Million)
11.1.6 North America: OTC Drug and Dietary Supplement Market, By Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.7 North America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.1.8 US: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.8.3 US: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.8.4 US: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.8.5 US: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.9 Canada: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Canada: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Canada: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Canada: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.10 Mexico: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.10.3 Mexico: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.10.4 Mexico: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.10.5 Mexico: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

12. Impact Of COVID-19 Pandemic On Global OTC Drug and Dietary Supplement Market
12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Company Profiles
13.1 GlaxoSmithKline plc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 AbbVie Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bausch Health Companies Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bayer AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Procter & Gamble
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Novartis AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Reckitt Benckiser Group Plc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 Glossary of Terms

Figure 1. OTC Drug and Dietary Supplement Market Segmentation
Figure 2. OTC Drug and Dietary Supplement Segmentation - By Region
Figure 3. North America OTC Drug and Dietary Supplement Market Overview
Figure 4. Analgesics Segment Held Largest Share of OTC Drug and Dietary Supplement
Figure 5. OTC Drug and Dietary Supplement Market in US to Show Remarkable Growth During Forecast Period
Figure 6. OTC Drug and Dietary Supplement Market- Leading Country Markets (US$ Million)
Figure 7. North America PEST Analysis
Figure 8. OTC Drug and Dietary Supplement Impact Analysis Of Driver And Restraints
Figure 9. North America OTC Drug and Dietary Supplement Market - Revenue Forecast And Analysis - 2019- 2027
Figure 10. OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
Figure 11. Cough and Cold Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Analgesics: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Gastrointestinal Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Sleep Aids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Oral Care Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Ophthalmic Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Antacids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Feminine Care: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 21. OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
Figure 22. Branded: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Generic: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 24. OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027 (%)
Figure 25. Tablets: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Capsules: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Powders: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Ointments: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Liquid: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 31. OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027 (%)
Figure 32. Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 33. Retail Stores: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 34. Online Channels: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 35. Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 36. North America: OTC Drug and Dietary Supplement Market, by Key Country - Revenue (2019) (USD Million)
Figure 37. North America: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
Figure 38. North America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 39. US: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
Figure 40. Canada: OTC Drug And Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
Figure 41. Mexico: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
Figure 42. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement market in North American Countries

Table 1. North America: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 2. North America: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. North America: OTC Drug and Dietary Supplement Market, By Form - Revenue and Forecast to 2027 (USD Million)
Table 4. North America: OTC Drug and Dietary Supplement Market, By Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 5. US: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 6. US: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 7. US: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
Table 8. US: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 10. Canada: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. Glossary of Terms, OTC Drug and Dietary Supplement



The List of Companies - North America OTC Drug and Dietary Supplement Market
1. GlaxoSmithKline plc.
2. Sanofi
3. Johnson and Johnson Services, Inc.
4. Abbott
5. AbbVie Inc.
6. Bausch Health Companies Inc.
7. Bayer AG
8. Procter & Gamble
9. Novartis AG
10. Reckitt Benckiser Group Plc